Cargando…
Diagnosis and Treatment for Mild Cognitive Impairment: A Systematic Review of Clinical Practice Guidelines and Consensus Statements
Background: Mild cognitive impairment (MCI) is an important stage between the normal cognitive decline of aging and dementia. The aim of this study was to compare and harmonize the recommendations for the diagnosis and treatment of MCI based on current clinical practice guidelines. Methods: We searc...
Autores principales: | Chen, Ya-Xin, Liang, Ning, Li, Xiao-Ling, Yang, Si-Hong, Wang, Yan-Ping, Shi, Nan-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545868/ https://www.ncbi.nlm.nih.gov/pubmed/34712197 http://dx.doi.org/10.3389/fneur.2021.719849 |
Ejemplares similares
-
Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023) -
The Clinical Course of Early and Late Mild Cognitive Impairment
por: Lin, Szu-Ying, et al.
Publicado: (2022) -
A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease
por: Li, Dan, et al.
Publicado: (2022) -
Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements
por: Li, Qianrui, et al.
Publicado: (2019) -
Screening for Cognitive Impairment After Stroke: Validation of the Chinese Version of the Quick Mild Cognitive Impairment Screen
por: Xu, Yangfan, et al.
Publicado: (2021)